[1] Clarke M, Green J S, Harper W M et al. Screening for deep-venout hrombosis after hip and knee replacement without prophylaxis[J]. Journal of Bone and Joint Surgery, 79, 787-791(1997).

[2] Freedman K B, Brookenthal K R, Fitzgerald R H, et al. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty[J]. The Journal of Bone and Joint Surgery, 82-A, 929-938(2000).

[3] Qu H X, Liu Y P. Research progress on risk factors and pathogenesis of deep venous thrombosis in orthopedics[J]. Orthopedic Journal of China, 17, 110-112(2009).

[4] Wang M, Meng S, Guo J H et al. Monte Carlo simulation analysis of pulmonary embolism detection by visual China people[J]. Chinese Journal of Lasers, 49, 2407103(2022).

[5] Silverstein M D, Heit J A, Mohr D N et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study[J]. Archives of Internal Medicine, 158, 585-593(1998).

[6] Perzborn E, Strassburger J, Wilmen A et al. In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939: an oral, direct Factor Xa inhibitor[J]. Journal of Thrombosis and Haemostasis, 3, 514-521(2005).

[7] Varin R, Mirshahi S, Mirshahi P et al. Effect of rivaroxaban, an oral direct factor Xa inhibitor, on whole blood clot permeation and thrombolysis: critical role of red blood cells[J]. Blood, 114, 1064(2009).

[8] Mueck W, Lensing A W A, Agnelli G et al. Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention[J]. Clinical Pharmacokinetics, 50, 675-686(2011).

[9] Kubitza D, Becka M, Wensing G et al. Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects[J]. European Journal of Clinical Pharmacology, 61, 873-880(2005).

[10] Ma Y H, Zhang S. Research progress on drug prevention of deep venous thrombosis in orthopedics[J]. Modern Medicine Journal of China, 12, 134-136(2010).

[11] Kubitza D, Becka M, Voith B et al. Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor[J]. Clinical Pharmacology & Therapeutics, 78, 412-421(2005).

[12] Zhu Z Y. Standardization of determination of prothrombin time and activated partial thromboplastin time (with recommended method of fibrinogen determination and suggestion of eliminating outdated clotting time)[J]. Chinese Journal of Laboratory Medicine, 21, 308-312(1998).

[13] Lu Y Z, Feng L, Jiang X G et al. Construction of a molecular structure model of mild-oxidized Chinese lignite using Gaussian09 based on data from FTIR, solid state 13C-NMR[J]. Journal of Molecular Modeling, 24, 135(2018).

[14] Jin Z M, Peng Y, Fang Y Q et al. Photoinduced large polaron transport and dynamics in organic–inorganic hybrid lead halide perovskite with terahertz probes[J]. Light: Science & Applications, 11, 1-12(2022).

[15] Shi C J, Wu X, Peng Y. Applications of terahertz imaging technology in tumor detection[J]. Opto-Electronic Engineering, 47, 190638(2020).

[16] Peng Y, Huang J L, Luo J et al. Three-step one-way model in terahertz biomedical detection[J]. PhotoniX, 2, 1-18(2021).

[17] Zhu Y M, Shi C J, Wu X et al. Terahertz spectroscopy algorithms for biomedical detection[J]. Acta Optica Sinica, 41, 0130001(2021).

[18] Liu X S, Zhao G S, Qu Y. Experimental analysis of four gastrointestinal drugs by terahertz spectroscopy[J]. Laser & Optoelectronics Progress, 60, 2330001(2023).

[19] Rustichelli C, Gamberini G, Ferioli V et al. Solid-state study of polymorphic drugs: carbamazepine[J]. Journal of Pharmaceutical and Biomedical Analysis, 23, 41-54(2000).

[20] Zeitler J A. Pharmaceutical terahertz spectroscopy and imaging[M]. Müllertz A, Perrie Y, Rades T. Analytical techniques in the pharmaceutical sciences. Advances in delivery science and technology, 171-222(2016).

[21] Suresh K, Ashe J S, Matzger A J. Far-infrared spectroscopy as a probe for polymorph discrimination[J]. Journal of Pharmaceutical Sciences, 108, 1915-1920(2019).

[22] Hakey P M, Allis D G, Ouellette W et al. Cryogenic terahertz spectrum of (+)-methamphetamine hydrochloride and assignment using solid-state density functional theory[J]. The Journal of Physical Chemistry A, 113, 5119-5127(2009).

[23] Ruggiero M T, Bardon T, Strlič M et al. Assignment of the terahertz spectra of crystalline copper sulfate and its hydrates via solid-state density functional theory[J]. The Journal of Physical Chemistry A, 118, 10101-10108(2014).

[24] Kazachenko A S, Tomilin F N, Pozdnyakova A A et al. Theoretical DFT interpretation of infrared spectra of biologically active arabinogalactan sulphated derivatives[J]. Chemical Papers, 74, 4103-4113(2020).

[25] Wallace S, Lambrakos S G, Shabaev A et al. IR absorption spectra for pesticides using density functional theory[J]. Proceedings of SPIE, 12091, 120910D(2022).